Home › United Therapeutics submits pre-market approval application for use...
 

Keywords :   


United Therapeutics submits pre-market approval application for use...

2014-12-26 10:50:53| Biotech - Topix.net

United Therapeutics Corporation announced today that Medtronic, Inc. has submitted a pre-market approval application to the U.S. Food and Drug Administration for the use of Medtronic's SynchroMedA II implantable drug infusion system for use with United Therapeutics' RemodulinA Injection delivered intravenously to patients with pulmonary arterial hypertension.

Tags: use united application approval

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news
»
02.07M13 Graphics invests in Landa digital press
02.07ABG helps Nordvalls increase productivity
02.07Tesla sales rise sharply after slump
02.07Hurricane Beryl Graphics
02.07Hurricane Beryl Forecast Discussion Number 16
02.07Fedrigoni teams with Progetto Quid
02.07Hurricane Beryl Forecast Advisory Number 16
02.07Hurricane Beryl Public Advisory Number 16
More »